BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 20472491)

  • 1. The evolving role of molecular diversity in drug discovery.
    Marcaurelle LA; Foley MA
    Curr Opin Chem Biol; 2010 Jun; 14(3):285-8. PubMed ID: 20472491
    [No Abstract]   [Full Text] [Related]  

  • 2. Genetic interventions in mammalian cells; applications and uses in high-throughput screening and drug discovery.
    Hampton SL; Kinnaird AI
    Cell Biol Toxicol; 2010 Feb; 26(1):43-55. PubMed ID: 19904619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Databases of protein-protein interactions and their use in drug discovery.
    Fuentes G; Oyarzabal J; Rojas AM
    Curr Opin Drug Discov Devel; 2009 May; 12(3):358-66. PubMed ID: 19396737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cheminformatics approaches to analyze diversity in compound screening libraries.
    Akella LB; DeCaprio D
    Curr Opin Chem Biol; 2010 Jun; 14(3):325-30. PubMed ID: 20457001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Fragment-based lead discovery from smaller fragments to functional ligand].
    Hatayama A; Habashita H
    Tanpakushitsu Kakusan Koso; 2009 Sep; 54(12 Suppl):1611-6. PubMed ID: 21089596
    [No Abstract]   [Full Text] [Related]  

  • 6. Fragment-Based Drug Discovery--CHI's Fourth Annual Meeting. 6-7 April 2009, San Diego, CA, USA.
    Seneci P
    IDrugs; 2009 Jun; 12(6):353-7. PubMed ID: 19517314
    [No Abstract]   [Full Text] [Related]  

  • 7. [NMR in the fragment-based drug discovery].
    Hanzawa H; Takizawa T
    Tanpakushitsu Kakusan Koso; 2009 Sep; 54(12 Suppl):1617-21. PubMed ID: 21089597
    [No Abstract]   [Full Text] [Related]  

  • 8. The application of next-generation sequencing technologies to drug discovery and development.
    Woollard PM; Mehta NA; Vamathevan JJ; Van Horn S; Bonde BK; Dow DJ
    Drug Discov Today; 2011 Jun; 16(11-12):512-9. PubMed ID: 21440664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Practice of fragment-based lead discovery by X-rays].
    Yamano A
    Tanpakushitsu Kakusan Koso; 2009 Sep; 54(12 Suppl):1622-7. PubMed ID: 21089598
    [No Abstract]   [Full Text] [Related]  

  • 10. [Construction of natural products library and its usage for drug discovery].
    Saito T; Nogawa T; Kato N; Kondoh Y; Osada H
    Tanpakushitsu Kakusan Koso; 2009 Sep; 54(12 Suppl):1551-6. PubMed ID: 21089587
    [No Abstract]   [Full Text] [Related]  

  • 11. Hypothesis-driven screening.
    Schopfer U; Engeloch C; Höhn F; Mees H; Leeds J; Glickman F; Scheel G; Ferrand S; Fekkes P; Pfeifer M
    Methods Mol Biol; 2009; 575():297-316. PubMed ID: 19727621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural genomics approach to drug discovery for Mycobacterium tuberculosis.
    Ioerger TR; Sacchettini JC
    Curr Opin Microbiol; 2009 Jun; 12(3):318-25. PubMed ID: 19481971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [From systematic analysis of protein interaction networks to chemical biology].
    Natsume T
    Tanpakushitsu Kakusan Koso; 2009 Sep; 54(12 Suppl):1628-33. PubMed ID: 21089599
    [No Abstract]   [Full Text] [Related]  

  • 14. Modern phenotypic drug discovery is a viable, neoclassic pharma strategy.
    Lee JA; Uhlik MT; Moxham CM; Tomandl D; Sall DJ
    J Med Chem; 2012 May; 55(10):4527-38. PubMed ID: 22409666
    [No Abstract]   [Full Text] [Related]  

  • 15. A novel imaging-based high-throughput screening approach to anti-angiogenic drug discovery.
    Evensen L; Micklem DR; Link W; Lorens JB
    Cytometry A; 2010 Jan; 77(1):41-51. PubMed ID: 19834964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of new technologies for cellular screening along the drug value chain.
    Möller C; Slack M
    Drug Discov Today; 2010 May; 15(9-10):384-90. PubMed ID: 20206290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renaissance of ion channel research and drug discovery by patch clamp automation.
    Fertig N; Farre C
    Future Med Chem; 2010 May; 2(5):691-5. PubMed ID: 21426196
    [No Abstract]   [Full Text] [Related]  

  • 18. [Study on ion channel transporters as a target for the drug discovery].
    Imaizumi Y; Kaneko S
    Nihon Yakurigaku Zasshi; 2011 Dec; 138(6):227. PubMed ID: 22303567
    [No Abstract]   [Full Text] [Related]  

  • 19. [Integrative in silico approach to assess the druggability of protein-protein interactions].
    Sugaya N
    Tanpakushitsu Kakusan Koso; 2009 Sep; 54(12 Suppl):1641-6. PubMed ID: 21089601
    [No Abstract]   [Full Text] [Related]  

  • 20. High-throughput discovery of Mycobacterium tuberculosis protein tyrosine phosphatase B (MptpB) inhibitors using click chemistry.
    Tan LP; Wu H; Yang PY; Kalesh KA; Zhang X; Hu M; Srinivasan R; Yao SQ
    Org Lett; 2009 Nov; 11(22):5102-5. PubMed ID: 19852491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.